The Impact of Antiangiogenic Therapy Combined With Transarterial Chemoembolization on Enhancement Based Quantitative Tumor Response Assessment in Patients With Hepatocellular Carcinoma

PURPOSE: To investigate whether Bevacizumab compromises early response assessment after Transarterial Chemoembolization (TACE) in patients with hepatocellular carcinoma by 3D quantitative European Association for the Study of the Liver (qEASL) criteria in comparison to other imaging-based criteria....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Imaging
Main Authors: Smolka, Susanne, Chapiro, Julius, Manzano, Wilfred, Treilhard, John, Reiner, Eric, Deng, Yanhong, Zhao, Yan, Hamm, Bernd, Duncan, James S, Gebauer, Bernhard, Lin, MingDe, Geschwind, Jean-François
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5720941/
https://ncbi.nlm.nih.gov/pubmed/28668723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clinimag.2017.05.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados